Management of Hepatocellular Cancer in the time of SARS-CoV-2

被引：11
作者：
Sharma, Rohini [1 ]
Pinato, David J. [1 ]
机构：
[1] Imperial Coll London, Hammersmith Hosp, Dept Surg & Canc, London, England
来源：
LIVER INTERNATIONAL | 2020年 / 40卷 / 08期
关键词：
Ablation; COVID-19; Hepatocellular carcinoma; Surgery; TACE; Tyrosine kinase inhibitor;
D O I：
10.1111/liv.14517
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1823 / 1825
页数：3
相关论文
共 7 条
  • [1] Boettler T, 2020, J HEP REPORTS
  • [2] European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019
  • [3] FIX OK, 2020, HEPATOLOGY
  • [4] Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
    Liang, Wenhua
    Guan, Weijie
    Chen, Ruchong
    Wang, Wei
    Li, Jianfu
    Xu, Ke
    Li, Caichen
    Ai, Qing
    Lu, Weixiang
    Liang, Hengrui
    Li, Shiyue
    He, Jianxing
    [J]. LANCET ONCOLOGY, 2020, 21 (03) : 335 - 337
  • [5] Review article: delivering precision oncology in intermediate-stage liver cancer
    Pinato, D. J.
    Howell, J.
    Ramaswami, R.
    Sharma, R.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (12) : 1514 - 1523
  • [6] Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study
    Reiss, Kim A.
    Yu, Shun
    Mamtani, Ronac
    Mehta, Rajni
    D'Addeo, Kathryn
    Wileyto, E. Paul
    Taddei, Tamar H.
    Kaplan, David E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31) : 3575 - +
  • [7] Vicini E, 2020, EUR J SURG ONCOL
1